The popularity of Viagra initially drove a period of growth for pharma, nevertheless recent developments present a murky outlook for those considering a stake. Lower-cost alternatives are eroding earnings, and https://frasertucr544937.glifeblog.com/39825361/sildenafil-and-big-pharma-a-volatile-investment